long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency

a fatty acid oxidation disorder; patients may experience episodes of acute hypoketotic hypoglycemia (similar to that found in MCAD deficiency), cardiomyopathy, muscle weakness, and liver abnormalities.

Mentioned in ?

LCHAD deficiency

References in periodicals archive ?

Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency

Mito-conundrum: unraveling environmental effects on mitochondria

Dietary management of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (LCHADD).

Patologia molecular de los errores hereditarios de la [beta]-oxidacion mitochondrial de los acidos grasos: alcances en el diagnostico y tratamiento

Secondary 3-hydroxydicarboxylic aciduria mimicking long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency.

Metabolic, nutritional, iatrogenic, and artifactual sources of urinary organic acids: a comprehensive table

Acylcarnitines in fibroblasts of patients with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency and other fatty acid oxidation disorders.

Accumulation of free 3-hydroxy fatty acids in the culture media of fibroblasts from patients deficient in long-chain L-3-hydroxyacyl-CoA dehydrogenase: a useful diagnostic aid

Molecular basis of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency.

Common missense mutation G1528 in long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency.

Improved stable isotope dilution-gas chromatography-mass spectrometry method for serum or plasma free 3-hydroxy-fatty acids and its utility for the study of disorders of mitochondrial fatty acid [beta]-oxidation

Acute fatty liver of pregnancy and long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency.

Stability of long-chain and short-chain 3-hydroxyacyl-CoA dehyd rogenase activity in postmortem liver